Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Definitive Nomenclature of GES/IBC-Type Extended-Spectrum ${\beta}-Lactamases$

  • Weldhagen Gerhard F. (Molecular Biology Laboratory, AMPATH National Laboratory Services and Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria) ;
  • Kim, Bok-Hee (Bio Technology Innovation Center, Youngdong University) ;
  • Cho, Chan-Hwi (Bio Technology Innovation Center, Youngdong University) ;
  • Lee, Sang-Hee (Bio Technology Innovation Center, Youngdong University)
  • Published : 2006.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Because there are no unified nomenclature systems for either GES-type or IBC-type extended-spectrum ${\beta}-lactamases$ (ESBLs), we propose a unified and definitive nomenclature system for GES/IBC-type ESBLs. This proposed nomenclature update is greatly helpful in two points: (i) it would not confuse microbiologists studying GES-type ESBLs, fundamentally preventing misleading nomenclature of these antibiotic resistance genes, and (ii) the definitive renaming of GES/IBC-type ESBLs can help some researchers to correctly designate new GES-type ESBLs such as novel enzymes identified trom some nationwide surveys.

Keywords

References

  1. Bradford, P. A. 2001. Extended-spectrum ${\beta}$-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-951 https://doi.org/10.1128/CMR.14.4.933-951.2001
  2. Castanheira, M., R. E. Mendes, T. R. Walsh, A. C. Gales, and R. N. Jones. 2004. Emergence of the extended-spectrum ${\beta}$-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: Report from the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 48: 2344-2345 https://doi.org/10.1128/AAC.48.6.2344-2345.2004
  3. Cho, B. G., C. H. Kim, B. K. Lee, and S. H. Cho. 2005. Comparison of antibiotic resistance of blood culture strains and saprophytic isolates in the presence of biofilms, formed by the intercellular adhesion (ica) gene cluster in Staphylococcus epidermidis. J. Microbiol. Biotechnol. 15: 728-733
  4. Correia, M., F. Boavida, F. Grosso, M. J. Salgado, L. M. Lito, J. Melo Cristino, S. Mendo, and A. Duarte. 2003. Molecular characterization of a new class 3 integron in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 47: 2838-2843 https://doi.org/10.1128/AAC.47.9.2838-2843.2003
  5. Duarte, A., F. Boavida, F. Grosso, M. Correia, L. M. Lito, J. Melo Cristino, and M. J. Salgado. 2003. Outbreak of GES-1 ${\beta}$-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob. Agents Chemother. 47: 1481-1482 https://doi.org/10.1128/AAC.47.4.1481-1482.2003
  6. George, H. T., J. Bradley, J. E. Edwards Jr., D. Gilbert, M. Scheld, and J. G. Bartlett. 2006. Bad bugs need drugs; an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42: 657-668 https://doi.org/10.1086/499819
  7. Giakkoupi, P., L. S. Tzouvelekis, A. Tsakris, V. Loukova, D. Sofianou, and E. Tzelepi. 2000. IBC-1, a novel integron-associated class A ${\beta}$-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44: 2247-2253 https://doi.org/10.1128/AAC.44.9.2247-2253.2000
  8. Hall, R., S. Partridge, P. A. Bradford, K. Bush, G. A. Jacoby, L. B. Rice, and L. S. Young. 2003. Unambiguous numbering of antibiotic resistance genes. Antimicrob. Agents Chemother. 47: 3998-3999 https://doi.org/10.1128/AAC.47.12.3998-3999.2003
  9. Jeong, S. H., I. K. Bae, D. Kim, S. G. Hong, J. S. Song, J. H. Lee, and S. H. Lee. 2005. First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum ${\beta}$-lactamases in Korea. Antimicrob. Agents Chemother. 49: 4809-4810 https://doi.org/10.1128/AAC.49.11.4809-4810.2005
  10. Jung, H. J., K. S. Choi, and D. G. Lee. 2005. Synergistic killing effect of synthetic peptide P20 and cefotaxime on methicillin-resistant nosocomial isolates of Staphylococcus aureus. J. Microbiol. Biotechnol. 15: 1039-1046
  11. Kim, J. N., S. J. Lee, H. S. Lee, and H. G. Rhie. 2005. Inactivation of mutS leads to a multiple-drug resistance in Pseudomonas putida ATCC12633. J. Microbiol. Biotechnol. 15: 1214-1220
  12. Lee, S. H., S. H. Jeong, J.-I. Wachino, T. Arakawa, L. Poirel, and P. Nordmann. 2005. Nomenclature of GES-type extended-spectrum ${\beta}$-lactamases. Antimicrob. Agents Chemother. 49: 2148-2150 https://doi.org/10.1128/AAC.49.5.2148-2150.2005
  13. Lee, S. H., S. H. Jeong, and S.-S. Cha. 2005. Minimising antibiotic resistance. Lancet Infect. Dis. 5: 668-670 https://doi.org/10.1016/S1473-3099(05)70247-4
  14. Lee, J. H. and S. H. Lee. 2006. Carbapenem resistance in Gram-negative pathogens: Emerging non-metallo-carbapenemases. Res. J. Microbiol. 1: 1-22 https://doi.org/10.3923/jm.2006.1.22
  15. Livermore, D. M. 1995. ${\beta}$-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584
  16. Mavroidi, A., E. Tzelepi, A. Tsakris, V. Miriagou, D. Sofianou, and L. S. Tzouvelekis. 2001. An integron-associated ${\beta}$-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum ${\beta}$-lactamase IBC-1. J. Antimicrob. Chemother. 48: 627-630 https://doi.org/10.1093/jac/48.5.627
  17. Pasteran, F., D. Faccone, A. Petroni, M. Rapoport, M. Galas, M. Vazquez, and A. Procopio. 2005. Novel variant $(bla_{VIM-11})$ of the metallo-${\beta}$-lactamase $bla_{VIM}$ family in a GES-1 extended-spectrum-${\beta}$-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob. Agents Chemother. 49: 474-475 https://doi.org/10.1128/AAC.49.1.474-475.2005
  18. Pasteran, F., D. Faccone, K. Campos, M. Vasquez, M. Rapoport, A. Littvik, M. Tokumoto, and M. Galas. 2004. Dissemination of GES extended-spectrum ${\beta}$-lactamase-producing Pseudomonas aeruginosa (PA) in Argentina. Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 105. American Society for Microbiology, Washington, D.C
  19. Paterson, D. L., W.-C. Ko, A. Von Gottberg, J. M. Casellas, L. Mulazimoglu, K. P. Klugman, R. A. Bonomo, L. B. Rice, J. G. McCormack, and V. L. Yu. 2001. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum ${\beta}$-lactamases: Implications for the clinical microbiology laboratory. J. Clin. Microbiol. 39: 2206-2212 https://doi.org/10.1128/JCM.39.6.2206-2212.2001
  20. Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A ${\beta}$-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45: 2598-2603 https://doi.org/10.1128/AAC.45.9.2598-2603.2001
  21. Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum ${\beta}$-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44: 622-632 https://doi.org/10.1128/AAC.44.3.622-632.2000
  22. Poirel, L., L. Brinas, N. Fortineau, and P. Nordmann. 2005. Integron-encoded GES-type extended-spectrum ${\beta}$-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49: 3593-3597 https://doi.org/10.1128/AAC.49.8.3593-3597.2005
  23. Rhie, H. G., S. J. Lee, and H. S. Lee. 2004. Characterization of the plasmid-encoded arsenic salts resistance determinant from Klebsiella oxytoca D12. J. Microbiol. Biotechnol. 14: 593-598
  24. Ryoo, N. H., E.-C. Kim, S. G. Hong, Y. J. Park, K. Lee, I. Kwon Bae, E. H. Song, and S. H. Jeong. 2005. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56: 698-702 https://doi.org/10.1093/jac/dki324
  25. Sanders, C. C. and W. E. Jr. Sanders. 1992. ${\beta}$-Lactamase in Gram-negative bacteria: Global trends and clinical impact. Clin. Infect. Dis. 15: 824-839 https://doi.org/10.1093/clind/15.5.824
  26. Vourli, S., P. Giakkoupi, V. Miriagou, E. Tzelepi, A. C. Vatopoulos, and L. S. Tzouvelekis. 2004. Novel GES/IBC extended-spectrum ${\beta}$-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol. Lett. 234: 209-213
  27. Wachino, J.-I., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, and Y. Arakawa. 2004. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A ${\beta}$-lactamase, GES-4, possessing a single G170S substitution in the ${\Omega}$-loop. Antimicrob. Agents Chemother. 48: 2905-2910 https://doi.org/10.1128/AAC.48.8.2905-2910.2004
  28. Wachino, J.-I., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, H. Ito, and Y. Arakawa. 2004. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A ${\beta}$-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob. Agents Chemother. 48: 1960-1967 https://doi.org/10.1128/AAC.48.6.1960-1967.2004
  29. Weldhagen, G. F. 2004. Rapid detection and sequence-specific differentiation of extended-spectrum ${\beta}$-lactamase GES-2 from Pseudomonas aeruginosa by use of a real-time PCR assay. Antimicrob. Agents Chemother. 48: 4059-4062 https://doi.org/10.1128/AAC.48.10.4059-4062.2004